Home Page >> Bleeding Deaths Associated with Pradaxa >> Articles >> Lawyer Interviews
Pradaxa Lawyer Interviews
September 9, 2014. By Brenda Craig.
Read [ Xarelto Litigation Story Still Unfolding ]
Louisville, KY Attorney David Koon sees more litigation ahead for anticoagulant Xarelto. Some is already in progress, but given the drug’s similarity to Praxada, another oral blood thinner with similar properties, Koon’s firm, Hughes & Coleman, is already preparing for failure to warn and product liability cases on behalf of people injured by Xarelto.
May 8, 2014. By Heidi Turner.
Read [ Attorney: Patients Did Not Realize Pradaxa Has No Antidote ]
Dallas, TX With thousands of Pradaxa lawsuits alleging patients suffered serious Pradaxa side effects pending, bellwether trials in the litigation have been scheduled and are expected to start in the coming months. Meanwhile, the maker of Pradaxa has been fined by a court for failing to preserve important documents. Dr. Shezad Malik, founder of the Dr. Shezad Malik Law Firm, says Pradaxa was marketed as being better than other drugs, but it came with serious risks.
September 14, 2012. By Heidi Turner.
Read [ Pradaxa Attorney: "There is No Antidote [to Pradaxa]" ]
Dallas, TX Lawsuits concerning Pradaxa side effects, including a reported risk of Pradaxa bleeding, have been filed against the maker of the blood thinner. These Pradaxa lawsuits allege patients were not adequately warned about the risks associated with the drug. Dr. Shezad Malik, founder of the Dr. Shezad Malik Law Firm says even though Pradaxa was marketed as a superior alternative to other drugs, it came with serious risks.
August 16, 2012. By Heidi Turner.
Read [ Attorney Jeff Lowe: Pradaxa Associated with Uncontrollable Bleeding ]
St. Louis, MO Although Pradaxa has only been on the market a couple of years, concerns about Pradaxa side effects are growing and lawsuits regarding Pradaxa problems, such as uncontrollable bleeding, have been filed. Among the concerns is the lack of an antidote to Pradaxa bleeding, which can put some patients at risk of serious consequences, according to Jeff Lowe, partner with Carey Danis & Lowe.